Picture of Viewray logo

VRAYQ Viewray Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual income statement for Viewray, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue8187.85770.1102
Cost of Revenue
Gross Profit6.6-5.48-4.060.33510
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses158209163174209
Operating Profit-77.5-121-106-104-107
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-76.4-120-108-110-107
Provision for Income Taxes
Net Income After Taxes-76.4-120-108-110-107
Net Income Before Extraordinary Items
Net Income-76.4-120-108-110-107
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-79.1-120-108-110-107
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.946-1.18-0.73-0.669-0.584